Star Combo Pharma Ltd (ASX: S66) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Star Combo Pharma Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Star Combo Pharma Ltd (ASX: S66)
Latest News
No posts found.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
14 Oct 2024 | $0.0037 | 100.00% | Final | 31 Oct 2024 |
S66 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Star Combo Pharma Ltd
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.
S66 Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
25 Nov 2024 | $0.12 | $0.00 | 0.00% | 1,921 | $0.12 | $0.12 | $0.12 |
20 Nov 2024 | $0.12 | $0.00 | 0.00% | 351 | $0.12 | $0.12 | $0.12 |
18 Nov 2024 | $0.12 | $0.00 | 0.00% | 65,375 | $0.12 | $0.12 | $0.12 |
14 Nov 2024 | $0.12 | $0.01 | 9.09% | 31,818 | $0.13 | $0.13 | $0.12 |
11 Nov 2024 | $0.11 | $-0.02 | -15.38% | 124,727 | $0.12 | $0.12 | $0.11 |
06 Nov 2024 | $0.13 | $-0.02 | -13.33% | 150,000 | $0.14 | $0.14 | $0.13 |
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Richard Ivan Allely | Non-Executive ChairmanNon-Executive Director | Feb 2018 |
Mr Allely has previously held non-executive roles on the boards of Australian Medical Publishing Company Pty Ltd, Perisher Blue Pty Ltd, Australian Property Monitors Pty Ltd and Source Financial Inc. (a USA Public Company). He has also been an independent member of Work Cover Authority of NSW and an advisory board member of Renoir Consulting Group. Richard was the Managing Director and CEO of PMP Ltd (PMP) until 2012, when he stepped down from the position, after serving just over 10 years with the company (seven years as CFO). Prior to this, Richard held senior executive roles with a number of leading Australian and International companies including Tenix Pty Ltd (formerly Transfield Pty Ltd), John Fairfax Holdings Ltd, Boral Ltd, James Hardie Industries Ltd and Fanner-PLP Pty Ltd. Richard has experience in the manufacturing, building and construction, and publication and media sectors within Australia and Southeast Asia.
|
Ms Su Zhang | Chief Executive OfficerExecutive DirectorJoint Company Secretary | Nov 2016 |
Ms Zhang has been working in the pharmaceutical industry for over 10 years, starting her career with Terry White Chemists. Upon leaving Terry White Chemists, Su worked for three years at Abbott Australia. She commenced at Abbott Australia as a Senior Drug Safety Associate and later moved into the role of Asia Pacific Regional Manager. In 2009, Su commenced employment with Star Combo, initially focusing her efforts on obtaining a TGA license for Costar Pharma. Su's responsibilities within Star Combo include quality control and compliance, operational management, production planning and sales cycle management.
|
Mr Star (JinXing) Zhang | Managing Director | Nov 2016 |
Mr Zhang is the founder of Star Combo and has a background in the pharmaceutical industry. After graduation from university, Star worked for 10 years at a medical research company in China which produced hard gel capsules, tablets and injections. While there, he pioneered the extraction and purification of hyaluronic acid, important as a lubricant in ocular surgery. Furthermore, he developed methods to separate low molecular weight hyaluronic acid, which is used in cosmetics. Star then immigrated to New Zealand, where he studied Commerce at the University of Auckland for one year. Upon returning to Australia, Star incorporated Star Combo in 2004 to address the need for high quality and affordable Australian-made health foods in the market.
|
Ms Wei Han | Non-Executive Director | May 2020 |
Ms Han has knowledge and experience in company governance of a listed company, compliance and financial management. Prior to joining Goldenmax International, Ms. Han has more than 30 years of specialised experience in company governance and accounting, providing professional services in the Chinese food and consumer industry.
|
Mr Jialong Ding | Non-Executive Director | May 2020 |
Mr Ding has over 30 years of experience in pharmaceutical distribution, production, and compliance. Prior to this, Mr. Ding held senior executive roles in several Chinese pharmaceutical companies, including subsidiaries of Shanghai Pharma. Mr. Ding was Vice President of China Nonprescription Medicines Association (CNMA) and Vice President of Shanghai Pharmaceutical Profession Association (SPPA).
|
Mr Patrick Raper | Company Secretary | Oct 2018 |
-
|
Mr James Ni | Chief Financial Officer |
-
|
|
Patrick Raper | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Goldenstar Pharmaceutical Investment Limited | 49,000,000 | 36.27% |
Jinxing(Star) Zhang | 38,165,510 | 28.25% |
Miss Su Zhang | 11,448,980 | 8.48% |
Lepu Medical (Europe) Cooperatief U.A. | 11,000,000 | 8.14% |
Certane Ct Pty Ltd | 3,541,178 | 2.62% |
Mr Liang Zuo | 2,243,512 | 1.66% |
Dw & Rl Pty Ltd | 2,163,335 | 1.60% |
Mr Jixiang Shi | 1,880,000 | 1.39% |
Dw & Rl Pty Ltd i | 1,270,934 | 0.94% |
Icomoon Pty Ltd | 1,202,090 | 0.89% |
Eureka Technology Innovation & Investment Pty Ltd | 623,000 | 0.46% |
Mr Brian Albert Donnelly | 507,658 | 0.38% |
Thi Uyen Phuong Nguyen | 500,000 | 0.37% |
Mrs Yun Cong Ye | 490,000 | 0.36% |
Mr Steve Hou | 472,238 | 0.35% |
Ms Lisha Huang | 455,000 | 0.34% |
Mr Huilin Lu | 381,681 | 0.28% |
Paul Thomas Hutchinson | 360,000 | 0.27% |
Mr Xing Kang Jin | 349,000 | 0.26% |
Mr Pisan Chowvalit | 343,727 | 0.26% |